Company Presentation
Azafaros B.V.
| Country: | The Netherlands/Switzerland |
| Category: | Clinical Stage Biotech Company |
| Room: | Samarkand |
| Date: | 22.04.2024. |
| Time: | 15:30 – 15:45 |
| Website: | https://www.azafaros.com |
| Speaker: | Dr Stefano Portolano, CEO |
Company profile
Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including our lead asset, nizubaglustat. Our focus is on developing disease-modifying therapies for patients with GM1 and GM2 gangliosidoses, and Niemann-Pick Disease Type C.
